Piramal Pharma Limited Announces Consolidated Results for Q1FY24 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), today announced its consolidated results for the first quarter (Q1) ended 30th June 2023..
/PRNewswire/ Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), today announced its consolidated results for the first quarter (Q1) ended 30th June 2023..
The persuasive Global G-CSF/PEG-G-CSF Market report suggests that the key market players are making moves like product launches, joint ventures, developments, mergers and acquisitions which has influence on the market and Healthcare industry as a whole and also affecting the sales, import, export, revenue and CAGR v.
/PRNewswire/ The "Global Allergic Rhinitis Drugs Market (2023-2028) by Class of Drugs, Route of Administration, Application, and Geography, Competitive.